RA Capital
Jonathan Pritz is an experienced professional in the field of investment management, currently serving as an Analyst and Senior Associate in the TechAtlas division of RA Capital Management, L.P., a firm focused on evidence-based investing in healthcare and life sciences. Previously, Jonathan Pritz worked as a Graduate Student Researcher at Dana-Farber Cancer Institute from September 2012 to December 2017. Jonathan Pritz holds a Doctor of Philosophy (PhD) in Biological Chemistry and Molecular Pharmacology from Harvard University and a Bachelor of Science (BS) in Microbiology and Cell Science from the University of Florida.
RA Capital
2 followers
RA Capital Management® (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics.